- Home
- TDUP vs OPK Comparison
TDUP vs OPK Comparison
Compare TDUP & OPK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TDUP
- OPK
- Stock Information
- Founded
- TDUP 2009
- OPK 2007
- Country
- TDUP United States
- OPK United States
- Employees
- TDUP N/A
- OPK N/A
- Industry
- TDUP Catalog/Specialty Distribution
- OPK Biotechnology: Pharmaceutical Preparations
- Sector
- TDUP Consumer Discretionary
- OPK Health Care
- Exchange
- TDUP Nasdaq
- OPK Nasdaq
- Market Cap
- TDUP 1.3B
- OPK 1.1B
- IPO Year
- TDUP 2021
- OPK 1995
- Fundamental
- Price
- TDUP $8.51
- OPK $1.42
- Analyst Decision
- TDUP Buy
- OPK Buy
- Analyst Count
- TDUP 3
- OPK 4
- Target Price
- TDUP $12.50
- OPK $2.28
- AVG Volume (30 Days)
- TDUP 1.5M
- OPK 1.8M
- Earning Date
- TDUP 11-03-2025
- OPK 10-29-2025
- Dividend Yield
- TDUP N/A
- OPK N/A
- EPS Growth
- TDUP N/A
- OPK N/A
- EPS
- TDUP N/A
- OPK N/A
- Revenue
- TDUP $277,729,000.00
- OPK $642,067,000.00
- Revenue This Year
- TDUP $18.15
- OPK N/A
- Revenue Next Year
- TDUP $9.93
- OPK $0.97
- P/E Ratio
- TDUP N/A
- OPK N/A
- Revenue Growth
- TDUP 20.14
- OPK N/A
- 52 Week Low
- TDUP $0.50
- OPK $1.11
- 52 Week High
- TDUP $12.28
- OPK $2.04
- Technical
- Relative Strength Index (RSI)
- TDUP 39.58
- OPK 40.81
- Support Level
- TDUP $8.49
- OPK $1.35
- Resistance Level
- TDUP $9.45
- OPK $1.50
- Average True Range (ATR)
- TDUP 0.42
- OPK 0.05
- MACD
- TDUP -0.01
- OPK -0.02
- Stochastic Oscillator
- TDUP 23.33
- OPK 23.81
About TDUP ThredUp Inc.
ThredUp Inc is an online resale platform for women and kids apparel, shoes, and accessories. It generates revenue from items that are sold to buyers through the website, mobile app and RaaS partners. Geographically, the majority of the company's revenue is generated from United States.
About OPK OPKO Health Inc.
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.